Skip to main content
UniHealth

Doctor search

Laura J Zitella, NP

Nurse Practitioner · San Francisco

NPI 1265570949

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
3
1 carrier
Office
1
Since medical school
29 years
Graduated 1997

Offices

1 location · University of California San Francisco · 1,780 clinicians in this group

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

3 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Laura J Zitella’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$64,883

Medicare paid this office $64,883 for 206 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)160$46,745$102
Return visit (30+ min)57$5,511$69
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's111$2,478$13
Short return visit (20+ min)21$1,099$48

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201720202021202220232024
Biopsy and aspiration of bone marrow sample for diagnosis–1631–––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

206 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 11% · Women 44% · Also on Medicaid 16% · Health risk score 2.60. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 64% · Chronic kidney disease 34% · Diabetes 22% · Coronary heart disease 21% · Atrial fibrillation 18% · Heart failure 16% · Cancer 16% · Depression 15% · COPD 14% · Stroke 7% · Dementia 6%.

The office billed $489,190, Medicare allowed $86,432 and paid $64,883; for 991 services of 13 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024206991752.60$489,190$64,883
2023169642752.85$433,645$58,327
2022145493723.11$353,788$48,424
2021161471723.31$358,830$47,892
20205172722.94$57,023$5,216
20171216671.54$37,636$774

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Long return visit (40+ min)133$48,393$107
Return visit (30+ min)39$3,850$69
Short return visit (20+ min)11$554$46

2022: 2 services

Original Medicare services billed in 2022
Long return visit (40+ min)124$44,353$105
Return visit (30+ min)27$2,833$75

2021: 3 services

Original Medicare services billed in 2021
Long return visit (40+ min)120$43,435$111
Return visit (30+ min)23$1,988$71
Biopsy and aspiration of bone marrow sample for diagnosis31$1,804$58

2020: 2 services

Original Medicare services billed in 2020
Long return visit (40+ min)29$3,846$80
Biopsy and aspiration of bone marrow sample for diagnosis16$1,004$63

Drugs they prescribed that Part D paid

$1,307,103

Pharmacies billed $1,307,103 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 2% of their Part D prescriptions (14 of 679) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

550 generic and fewer than 11 brand-name prescriptions · $1,307,103 in drug cost · 75 antibiotic prescriptions to 37 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Brukinsa42$553,798$13,186
Imbruvica31$489,351$15,786
Eliquis14$18,335$1,310
Atovaquone23$13,446$585
Entecavir13$6,306$485
See all 16 drugs
Every Part D drug this clinician prescribed
Brukinsa42$553,798$13,186
Imbruvica31$489,351$15,786
Eliquis14$18,335$1,310
Atovaquone23$13,446$585
Entecavir13$6,306$485
Valacyclovir54$2,789$52
Acyclovir70$2,173$31
Gabapentin25$329$13
Ondansetron13$317$24
Famotidine16$281$18
Sulfamethoxazole-Trimethoprim33$215$7
Allopurinol19$158$8
Trazodone11$114$10
Prednisone21$78$4
Levofloxacin11$73$7
Pantoprazole13$66$5

Year by year

Part D prescribing by year
20246791412% (14)None$1,307,103
20237011635% (36)None$1,656,651
20225891285% (32)None$1,268,149
2021337686% (20)8%$134,270
20202412NoneNone$2,599
20181712NoneNone$552
201711034NoneNone$126,211
20167320None25%$58,251
201517None0% (0)None$541
20145516NoneNone$7,461
20131002213% (13)16%$17,869

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 13 drugs

Part D drugs prescribed in 2023
Brukinsa45$583,671$12,970
Imbruvica36$581,863$16,163
Calquence12$191,549$15,962
Atovaquone22$16,597$754
Entecavir24$7,847$327
Valacyclovir45$3,024$67
Acyclovir99$2,439$25
Gabapentin25$593$24
Sulfamethoxazole-Trimethoprim53$583$11
Allopurinol18$168$9
Levofloxacin17$142$8
Famotidine17$111$7
Lorazepam11$58$5

2022: 17 drugs

Part D drugs prescribed in 2022
Brukinsa32$418,429$13,076
Iclusig12$258,216$21,518
Calquence13$187,097$14,392
Imbruvica11$154,503$14,046
Atovaquone21$18,151$864
Eliquis11$7,227$657
Acyclovir67$1,927$29
Valacyclovir29$1,521$52
Entecavir19$1,302$69
Gabapentin17$292$17
Sulfamethoxazole-Trimethoprim52$287$6
Oxycodone19$284$15
Famotidine11$269$24
Ondansetron14$202$14
Olanzapine13$197$15
Allopurinol16$174$11
Atorvastatin17$133$8

2021: 7 drugs

Part D drugs prescribed in 2021
Acyclovir20$533$27
Potassium Chloride16$522$33
Dexamethasone16$503$31
Famotidine14$196$14
Olanzapine11$112$10
Prednisone20$106$5
Sulfamethoxazole-Trimethoprim22$98$4

Money from drug and device companies

$2,795 in 2025

Industry payments by year
2025810$2,250$2,795
202437$150$698
202345$1,050$1,164
202234$3,475$3,650
202111None$99

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
E.R. Squibb & Sons L.L.C.None$1,200
1 payment
  • Consulting · 2025-10-29 · $1,200
PfizerElrexfio$1,050
2 payments
  • Consulting for Elrexfio · 2025-08-20 · $300
  • Consulting for Elrexfio · 2025-08-14 · $750
AbbvieVenclexta$136
2 payments
  • Meals for Venclexta · 2025-11-22 · $116
  • Meals for Imbruvica · 2025-01-30 · $21
Janssen BiotechTecvayli$125
1 payment
  • Meals for Tecvayli · 2025-11-22 · $125
GenzymeSarclisa$109
1 payment
  • Meals for Sarclisa · 2025-10-23 · $109
AstraZeneca Pharmaceuticals LPNone$83
1 payment
  • Meals · 2025-10-24 · $83
See all 10 published payments
Every published payment
Janssen BiotechMeals · 2025-11-22Tecvayli$125
AbbvieMeals · 2025-11-22Venclexta$116
E.R. Squibb & Sons L.L.C.Consulting · 2025-10-29None$1,200
AstraZeneca Pharmaceuticals LPMeals · 2025-10-24None$83
GenzymeMeals · 2025-10-23Sarclisa$109
PfizerConsulting · 2025-08-20Elrexfio$300
PfizerConsulting · 2025-08-14Elrexfio$750
AbbvieMeals · 2025-01-30Imbruvica$21
Ipsen BiopharmaceuticalsMeals · 2025-01-25Onivyde$76
Adaptive BiotechnologiesMeals · 2025-01-16Clonoseq$17
See earlier years (2024, 2023, 2022, 2021)

2024: $698

Payments by company in 2024
AbbvieEpkinly$327
4 payments
  • Meals for Epkinly · 2024-11-15 · $145
  • Meals for Imbruvica · 2024-10-04 · $20
  • Meals for Epkinly · 2024-05-15 · $11
  • Meals for Epkinly · 2024-05-02 · $150
BeiGene USABrukinsa$257
2 payments
  • Consulting for Brukinsa · 2024-10-18 · $150
  • Meals for Tevimbra · 2024-08-23 · $107
Janssen BiotechTecvayli$114
1 payment
  • Meals for Tecvayli · 2024-11-16 · $114

2023: $1,164

Payments by company in 2023
BeiGene USABrukinsa$1,050
1 payment
  • Consulting for Brukinsa · 2023-05-26 · $1,050
Pharmacyclics LLC An AbbVieImbruvica$47
2 payments
  • Meals for Imbruvica · 2023-10-25 · $17
  • Meals for Imbruvica · 2023-05-18 · $30
Janssen Scientific AffairsErleada$44
1 payment
  • Meals for Erleada · 2023-04-28 · $44
Kyowa KirinPoteligeo$24
1 payment
  • Education for Poteligeo · 2023-08-19 · $24

2022: $3,650

Payments by company in 2022
AbbvieVenclexta$2,475
1 payment
  • Consulting for Venclexta · 2022-08-26 · $2,475
E.R. Squibb & Sons L.L.C.None$1,000
1 payment
  • Paid to speak or teach · 2022-01-31 · $1,000
Janssen BiotechDarzalex$175
2 payments
  • Meals for Darzalex · 2022-09-08 · $125
  • Meals for Imbruvica · 2022-04-30 · $50

2021: $99

Payments by company in 2021
IncyteNone$99
1 payment
  • Education · 2021-04-27 · $99

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
75.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1265570949
Licence
CA NP10563
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 363LA2100X (363LA2100X); Nurse practitioner (363L00000X)
Mailing address
875 Blake Wilbur Dr, Mail Code 5820, Palo Alto, CA, 94304
NPI first listed
2007-02-02
NPI last updated
2026-04-27
NPI record certified
2026-04-27

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305